- Home
- IMNM vs EOSEW Comparison
IMNM vs EOSEW Comparison
Compare IMNM & EOSEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- EOSEW
- Stock Information
- Founded
- IMNM 2006
- EOSEW N/A
- Country
- IMNM United States
- EOSEW United States
- Employees
- IMNM N/A
- EOSEW 430
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- EOSEW Industrial Machinery/Components
- Sector
- IMNM Health Care
- EOSEW Miscellaneous
- Exchange
- IMNM Nasdaq
- EOSEW Nasdaq
- Market Cap
- IMNM 945.8M
- EOSEW N/A
- IPO Year
- IMNM 2020
- EOSEW N/A
- Fundamental
- Price
- IMNM $8.99
- EOSEW $0.51
- Analyst Decision
- IMNM Strong Buy
- EOSEW
- Analyst Count
- IMNM 8
- EOSEW 0
- Target Price
- IMNM $24.75
- EOSEW N/A
- AVG Volume (30 Days)
- IMNM 1.1M
- EOSEW 166.0K
- Earning Date
- IMNM 11-12-2025
- EOSEW 03-05-2025
- Dividend Yield
- IMNM N/A
- EOSEW N/A
- EPS Growth
- IMNM N/A
- EOSEW N/A
- EPS
- IMNM N/A
- EOSEW N/A
- Revenue
- IMNM $12,589,000.00
- EOSEW $14,963,000.00
- Revenue This Year
- IMNM N/A
- EOSEW N/A
- Revenue Next Year
- IMNM $154.73
- EOSEW N/A
- P/E Ratio
- IMNM N/A
- EOSEW N/A
- Revenue Growth
- IMNM 16.74
- EOSEW 20.34
- 52 Week Low
- IMNM $5.15
- EOSEW $0.07
- 52 Week High
- IMNM $16.55
- EOSEW $1.61
- Technical
- Relative Strength Index (RSI)
- IMNM 43.08
- EOSEW 58.56
- Support Level
- IMNM $9.01
- EOSEW $0.44
- Resistance Level
- IMNM $9.63
- EOSEW $0.60
- Average True Range (ATR)
- IMNM 0.71
- EOSEW 0.07
- MACD
- IMNM -0.07
- EOSEW 0.02
- Stochastic Oscillator
- IMNM 16.37
- EOSEW 58.82
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About EOSEW Eos Energy Enterprises Inc. Warrant
Eos Energy Enterprises Inc designs develop, manufactures, and markets zinc-based energy storage solutions for utility-scale, microgrid, and commercial & industrial (C&I) applications. The solutions are used in the utility sector, the renewable energy sector, and the industrial sector. It's flagship product Eos Znyth is a stationary battery energy storage system.